Portfolio company
Lembas
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops bioactive peptide ingredients for food and supplement manufacturers to help consumers manage weight through natural hormone regulation.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GlycoX
This company develops a plant-based food ingredient designed to provide blood-sugar control and support metabolic health for health-conscious consumers.
Ousia Pharma
This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.
BioLumen
BioLumen develops a structured fibre that absorbs sugars and fats to reduce calorie intake for consumers and food manufacturers.
The Akkermansia Company
The company develops and sells pasteurised gut microbiome supplements to consumers and health professionals for weight management and metabolic health.
Metabolize
This company develops dietary supplements for individuals managing weight after discontinuing or cycling off GLP-1 medications to help maintain muscle and regulate appetite.
Nuritas Limited
This company uses artificial intelligence to discover and provide natural peptide ingredients for health and nutrition brands to use in their product formulations.
Prolynx
The company develops long-acting medicines for obesity and metabolic conditions using proprietary drug delivery technology for patients requiring less frequent dosing.
MicroLub
This company develops protein-based ingredients that replace fats and oils in food and personal care products for manufacturers while maintaining texture and mouthfeel.
